Search Results

Displaying Results 1876-1900 of 55208 "'NEXT'"

Mar 31, 2026, 00:46 ET Toshiba Begins Sampling of 30-34TB SMR Nearline Hard Disk Drives

million hours, an annualized failure rate (AFR) of 0.35 %.Looking ahead, Toshiba plans to further increase HDD capacity through the adoption of next-generation recording technologies, including Heat Assisted Magnetic Recording (HAMR), and products featuring a 12-disk configuration[7].

More news about: Toshiba Electronic Components Taiwan Corporation


Mar 30, 2026, 21:57 ET DRVN Investors Have Opportunity to Lead Driven Brands Holdings Inc. Securities Fraud Lawsuit

Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.What to do next: To join the Driven Brands class action, go to

More news about: THE ROSEN LAW FIRM, P. A.


Mar 30, 2026, 21:00 ET EPG Adds Over US$100 Million in Series B+ Financing, Expanding Strategic Backing for Global AI Data Center Growth

business model enables faster deployment, lower environmental impact, and improved delivery certainty for customers. The new financing will support EPG's next phase of international growth, including expanding R&D, manufacturing, and delivery capabilities.As global demand for AI computing shifts

More news about: EPG Singapore Pte Ltd


Mar 30, 2026, 21:00 ET EPG Adds Over US$100 Million in Series B+ Financing, Expanding Strategic Backing for Global AI Data Center Growth

business model enables faster deployment, lower environmental impact, and improved delivery certainty for customers. The new financing will support EPG's next phase of international growth, including expanding R&D, manufacturing, and delivery capabilities.As global demand for AI computing shifts

More news about: EPG Singapore Pte Ltd


Mar 30, 2026, 20:39 ET Rosen Law Firm Encourages SYLA Technologies Co., Ltd. Investors to Inquire About Securities Class Action Investigation - SYT

or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.What to do next: To join the prospective class action, go to

More news about: The Rosen Law Firm, P.A.


Mar 30, 2026, 20:38 ET Rosen Law Firm Encourages Chanson International Holding Investors to Inquire About Securities Class Action Investigation - CHSN

or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.What to do next: To join the prospective class action, go to

More news about: THE ROSEN LAW FIRM, P. A.


Mar 30, 2026, 20:38 ET COTY Investors Have Opportunity to Lead Coty Inc. Securities Fraud Lawsuit

Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.What to do next: To join the Coty class action, go to

More news about: THE ROSEN LAW FIRM, P. A.


Mar 30, 2026, 20:22 ET "Please Bring It Back"--The Gen Z-Demanded 'Barrier-Saving Cleanser' by Dr.BRID C Just Dropped on Amazon

Amazon.About Dr.BRID C Dr.BRID C is a next-generation K-beauty biotech skincare brand founded on the philosophy of "Defense Before Beauty." Powered by 10 years of research and its proprietary

More news about: Dr.BRID C


Mar 30, 2026, 20:19 ET Richtech Robotics Deadline: RR Investors with Losses in Excess of $100K Have Opportunity to Lead Richtech Robotics Inc. Securities Fraud Lawsuit First Filed by the Rosen Law Firm

Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.What to do next: To join the Richtech class action, go to

More news about: THE ROSEN LAW FIRM, P. A.


Mar 30, 2026, 20:00 ET Innovent's Partner Ollin Biosciences Announces Final Data from Randomized Head-to-Head Study of IBI324 Compared to Faricimab (Vabysmo) in Wet Age-Related Macular Degeneration and Diabetic Macular Edema

scientific conferences.About the OLN324 JADE StudyJADE is a randomized, head-to-head Phase 1b clinical study comparing OLN324, a next-generation VEGF/Ang2 bispecific antibody, to faricimab (Vabysmo®), in patients with diabetic macular edema (DME) or wet (neovascular) age-related

More news about: Innovent Biologics


Mar 30, 2026, 19:57 ET New Christian Book Explores Genesis 3:16b and Offers a Transparent Journey of Faith, Marriage, and Redemption

her local church. She and her husband have been married for 44 years. They have three grown children and three grandchildren and are expecting a 4th next year. Helen has a deep passion for God's Word. To learn more, please visit:

More news about: WestBow Press


Mar 30, 2026, 19:15 ET Greenberg Traurig Recognized Across Europe and the Middle East by Legal 500 EMEA 2026 Edition

Alex Roussos — Capital MarketsIn addition, the guide recognizes 12 Greenberg Traurig lawyers on its "Next Generation Partners" list:Germany

More news about: Greenberg Traurig, LLP


Mar 30, 2026, 19:01 ET Material Intelligence in Motion: Engineering the Future of Adaptive Apparel at Functional Fabric Fair Spring 2026

do. From physiological-signal sensing and integrated climate control to motion-capture and muscle-stimulation, WIIM provides the architecture for the next generation of active apparel.FFF SP26 highlights include:LIGHTFIBER — a patented electroluminescent fiber and the world's

More news about: MAKALOT industrial co., ltd.


Mar 30, 2026, 18:19 ET New Christian Field Manual Offers Abundant Life Through Living in Lordship

comprehensive whole — a completely new creation: a disciple. Consequently, discipleship is the all-encompassing and nonnegotiable 'something more' and 'what's next' of Christianity."Living in Lordship presents the abundant life of discipleship as the practical and powerful antidote to fear, purposelessness

More news about: WestBow Press


Mar 30, 2026, 17:59 ET NAVN Investors Have Opportunity to Lead Navan, Inc. Securities Lawsuit

stock you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.What to do next: To join the Navan class action, go to

More news about: THE ROSEN LAW FIRM, P. A.


Mar 30, 2026, 17:52 ET POM Deadline: POM Investors with Losses in Excess of $100K Have Opportunity to Lead PomDoctor Ltd. Securities Fraud Lawsuit

Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.What to do next: To join the PomDoctor class action, go to

More news about: THE ROSEN LAW FIRM, P. A.


Mar 30, 2026, 17:52 ET Cancer Vaccine Coalition Commits $1 Million to Try to Stop Breast Cancer Recurrence Before It Starts

outcomes."About the Cancer Vaccine CoalitionThe Cancer Vaccine Coalition (CVC) is a nonprofit organization dedicated to advancing next-generation cancer immunotherapies. Founded by former NBC Correspondent, Kristen Dahlgren, along with survivors and scientists, CVC is focused on accelerating

More news about: Cancer Vaccine Coalition


Mar 30, 2026, 17:41 ET Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON

or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.What to do next: To join the prospective class action, go to

More news about: THE ROSEN LAW FIRM, P. A.


Mar 30, 2026, 17:40 ET BTQ Technologies Provides Full-Year 2025 Corporate Update Highlighting Commercial Progress Across QCIM, QPerfect, QSSN and Bitcoin Quantum

strategy designed to secure critical infrastructure for the post-quantum era while building enabling software, hardware, and network infrastructure for the next generation of quantum-secure systems. Across the year, the Company advanced commercialization pathways in secure silicon, deepened its role in post-quantum

More news about: BTQ Technologies Corp.


Mar 30, 2026, 17:37 ET Rosen Law Firm Encourages TruBridge, Inc. Investors to Inquire About Securities Class Action Investigation - TBRG

or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.What to do next: To join the prospective class action, go to

More news about: THE ROSEN LAW FIRM, P. A.


Mar 30, 2026, 17:30 ET STOP SLAGGING. START SAVING: Maximize Boiler Availability with Aurora™ at the 2026 International BioMass Show

and reliable supply from its extensive operations in the Americas."At Imerys, our minerals do more than improve performance; they enable the next generation of sustainable materials," said Matt Centa, Vice President Ceramics, Filtration & Life Sciences, Imerys Performance Minerals Americas.

More news about: Imerys


Mar 30, 2026, 17:28 ET RARE Deadline: RARE Investors with Losses in Excess of $100K Have Opportunity to Lead Ultragenyx Pharmaceutical Inc. Securities Fraud Lawsuit

Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.What to do next: To join the Ultragenyx class action, go to

More news about: THE ROSEN LAW FIRM, P. A.


Mar 30, 2026, 17:17 ET Robbins LLP Urges TCOM Stockholders Who Lost Money Investing in Trip.com Group Limited to Contact the Firm for Information About Leading the Class Action

monopolistic practices." On this news, the price of Trip.com ADSs fell $12.90 per ADS, or 17.05%, to close at $62.78 per ADS on January 14, 2026. The next day, it fell a further $1.48 per ADS, or 2.35%, to close at $61.30 on January 15, 2026.What can shareholders do now? You may be eligible

More news about: Robbins LLP


Mar 30, 2026, 17:16 ET Major Institutions are Positioning the $30B Supply Shift for Strategic Growth Potential - Equity Insider.com News Commentary

around the world, and their relevant experience in our neighbourhood, makes them a natural partner for Eagle as we plan to take Aurora toward the next stage of development," said Vishal Gupta, VP of Operations of Eagle. "The SLR team has been involved in extensive engagement with regulators

More news about: Equity Insider


Mar 30, 2026, 17:15 ET Apotex announces leadership changes

company, today announced key changes to its executive leadership structure designed to strengthen its long-term strategic direction and accelerate the company's next phase of growth. 

More news about: Apotex Inc.


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.